
Lower CD4 counts linked with higher cancer risks in people living with HIV in South Africa
A report in Clinical Infectious Diseases has said that immune suppression is linked with an increased risk of numerous cancers amongst people living with HIV, according to data collected and analysed in South Africa.
The study’s authors found links between a low CD4 count and increased risk of non-Hodgkin lymphoma, Kaposi’s sarcoma (KS) and HPV related cancers such as cervical cancer. The authors found no link between immune suppression and several non-infection linked cancers such as breast, lung and prostate.

24 märts 2021 13:44
Chinese HIV drug, Aikening, gets first approval outside China
The Republic of Ecuador has become the first country outside of China to authorise the sale and use of a HIV drug developed in China by Frontier Biotech.
Aikening (Albuvirtide 160mg) is a new long-acting injectable fusion inhibitor designed to be administered ...
Lugege edasi

22 märts 2021 15:12
AstraZeneca applies for FDA authorisation after study shows vaccine to be safe and effective
The AstraZeneca vaccine, developed in collaboration with Oxford University, is ‘highly effective’ at preventing COVID-19 in all age groups says the company following a Phase III trial in the US, Chile and Peru.
The trial, run by Columbia University and ...
Lugege edasi
Mis on Life4me+?
Üks Life4me+ peamiseid eesmärke on uute HIVi- ja muude sugulisel teel levivate nakkuste juhtumite, nagu ka C-hepatiiti ja tuberkuloosi nakatumise ennetamine. Seepärast räägime HIVist ja muudest haigustest — sellest, kuidas end nende eest kaitsta ja kuidas elada nakatununa.
Rohkem


Kampaania Life4me+
Info haridusliku kampaania "M = M" kohta ("Mittetuvastatav = mitteedasikanduv", #UequalsU, #НравноН), mis on Life4me+ poolt organiseeritud Ida-Euroopas ja Kesk-Aasias regioonis, suunatud info levitamisele, et HIV-positiivne inimene mittetuvastatava viiruskoormusega ei saa viirust seksuaalsel teel edasi kanda teisele inimesele.
Mitmed uuringud on näidanud, et diskordantses paaris, kus HIV-positiive partner võtab ARV ravimeid ja hoiab viiruskoormuse mittetuvastataval tasemel, ei ole teada juhtumitest, kus HIV oleks seksuaalsel teel edasi kandunud.
Meie partnerid